NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-27 Cr | ₹-2.88 Cr | ₹-20 Cr | ₹-21 Cr | - |
What is the latest Cash Flow from Investing Activities ratio of NATH BIOGENES (INDIA) ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-27 Cr |
Mar2023 | ₹-2.88 Cr |
Mar2022 | ₹-20 Cr |
Mar2013 | ₹-21 Cr |
Mar2012 | - |
How is Cash Flow from Investing Activities of NATH BIOGENES (INDIA) Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-27 Cr | Negative | |
Mar2023 | ₹-2.88 Cr | Negative | |
Mar2022 | ₹-20 Cr | Negative | |
Mar2013 | ₹-21 Cr | 0 | |
Mar2012 | - | - |
Compare Cash Flow from Investing Activities of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹377.2 Cr | -2.4% | 5.6% | -1% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,934.7 Cr | -5.8% | -6.3% | 14.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,436.8 Cr | -5.7% | -15.3% | 32.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,264.3 Cr | -1.5% | 0.4% | -16.7% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,435.5 Cr | -2% | -1.8% | -33.7% | Stock Analytics | |
INDO US BIOTECH | ₹307.9 Cr | 1.5% | 1.6% | -27% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -2.4% |
5.6% |
-1% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses